Ultra-low-frequency transcutaneous electric nerve stimulation (ULF-TENS) in subjects with craniofacial pain: A retrospective study

Mummolo, Stefano; Nota, Alessandro; Tecco, Simona; Caruso, Silvia; Marchetti, Enrico; Marzo, Giuseppe; Cutilli, T

doi:10.1080/08869634.2018.1526849

Cited by 27 publications

(26 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The method for sensory TENS was described previously [23–27]. Briefly, a J5 Myomonitor® TENS Unit device (Myotronics-Noromed, Inc., Tukwila, WA, USA) with disposable electrodes (Myotrode SG Electrodes®, Myotronics-Noromed, Inc., Tukwila, WA, USA) was used.…”

Section: Methodsmentioning

confidence: 99%

A Device Improves Signs and Symptoms of TMD

Pietropaoli

Cooper

Ortu

et al. 2019

Pain Research and Management

View full text Add to dashboard Cite

Background. Temporomandibular joint dysfunction (TMD) therapy remains an open challenge for modern dentistry. Herein, we propose a new neuromuscular lingual device able to reduce signs and symptoms of TMD in female patients with chronic orofacial pain. Methods. 50 females with myofascial TMD according to RDC/TMD were randomly assigned to study (n = 25) and control groups (n = 25). At T0, both groups received sEMG/KNG and pain evaluation by the VAS scale. The study group received the ELIBA device (lingual elevator by Balercia) constructed under ULF-TENS (ultra-low-frequency transcoutaneous electrical nervous stimulation). Subjects were instructed to use ELIBA at least for 16 h/day. After 6 months (T1), both groups underwent to sEMG/KNG and VAS revaluation. Results. T1 study group compared to controls showed a significant reduction in total (p<0.0001) and mean (p<0.0001) sEMG values, as well as a significant increase in both maximum vertical mouth opening (p=0.003) and maximum velocity in mouth opening (p=0.003) and closing (p<0.0001). Interestingly, a significant reduction in pain measured by VAS (p<0.0001) was reported. Conclusions. After 6 months, the ELIBA device is able to significantly reduce TMD-associated myogenous pain and to promote the enhancement of sEMG/KNG values. Practical Implications. ELIBA can be considered as a new device, potentially useful for head-neck pain relief in patients suffering from chronic TMD. In addition, its use promotes a muscles relaxation inducing freeway space increase. This characteristic makes it particularly useful for rehabilitation of patients with not enough space for construction of conventional orthotics or neuromuscular bites.

show abstract

Section: Methodsmentioning

confidence: 99%

A Device Improves Signs and Symptoms of TMD

Pietropaoli

Cooper

Ortu

et al. 2019

Pain Research and Management

View full text Add to dashboard Cite

show abstract

“…In both groups, at T0, the greater part of the parameters demonstrated values out of the normal range, while at T2, the majority of parameters in both groups changed significantly reaching the normal range showing a general improvement of muscular function and symmetry in both groups [12,24]. No significant differences were observed concerning ∆ (delta) variation over time between digital and traditional techniques.…”

Section: Discussionmentioning

confidence: 84%

Evaluation of Masticatory Muscle Function Using Digital versus Traditional Techniques for Mockup Fabrication: A Controlled Prospective Study

et al. 2020

Self Cite

View full text Add to dashboard Cite

Background: the aim of this longitudinal prospective study was to analyze the effect of digital and traditional mockup on masticatory muscle activity in patients with teeth wear, rehabilitated with an increase of occlusal vertical dimension. Subjects and Methods: a sample of 22 adult patients who were about to receive a prosthetic rehabilitation was divided into a study group (3M; 9F; mean age 42 ± 0.8 years), treated using the digital mockup; and a control group (2M; 8F; mean age 37 ± 0.5 years), treated using the conventional technique (traditional) mockup. Electromyographic activity of anterior temporalis and masseter muscles were evaluated before the beginning of the treatment (T0), at mockup insertion (T1), after treatment (T2) and each lapse of time lasted 2–5 months. Results: the comparison between the two groups at different time gaps revealed that at ∆1 (T1–T0) only the impact index (IMP) showed significant difference and no other significant variation was observed between the two groups at ∆2 (T2–T1) and ∆3 (T2–T0). It concludes that traditional and digital methods generally have nonsignificant differences. Conclusions: both methods seem to be effective in prosthetic rehabilitation and give comparable effects on masticatory muscles.

show abstract

“…However, previous evidence demonstrated that ULF-TENS could attenuate movement-evoked pain and improve jaw motor function during repeated jaw movements in patients with TMD and disc displacement without reduction [ 23 ]. A retrospective study also demonstrated marked improvement after ULF-TENS along with gradual and progressive disappearance of referred pain symptoms in subjects with craniofacial pain [ 24 ]. There is no published study reporting the side effects of ULF-TENS in TMD patients.…”

Section: Discussionmentioning

confidence: 99%

Ultra-Low Frequency Transcutaneous Electrical Nerve Stimulation on Pain Modulation in a Rat Model with Myogenous Temporomandibular Dysfunction

Hsieh

Yang²,

Yang

2021

IJMS

View full text Add to dashboard Cite

Masticatory myofascial pain (MMP) is one of the most common causes of chronic orofacial pain in patients with temporomandibular disorders. To explore the antinociceptive effects of ultra-low frequency transcutaneous electrical nerve stimulation (ULF-TENS) on alterations of pain-related biochemicals, electrophysiology and jaw-opening movement in an animal model with MMP, a total of 40 rats were randomly and equally assigned to four groups; i.e., animals with MMP receiving either ULF-TENS or sham treatment, as well as those with sham-MMP receiving either ULF-TENS or sham treatment. MMP was induced by electrically stimulated repetitive tetanic contraction of masticatory muscle for 14 days. ULF-TENS was then performed at myofascial trigger points of masticatory muscles for seven days. Measurable outcomes included maximum jaw-opening distance, prevalence of endplate noise (EPN), and immunohistochemistry for substance P (SP) and μ-opiate receptors (MOR) in parabrachial nucleus and c-Fos in rostral ventromedial medulla. There were significant improvements in maximum jaw-opening distance and EPN prevalence after ULF-TENS in animals with MMP. ULF-TENS also significantly reduced SP overexpression, increased MOR expression in parabrachial nucleus, and increased c-Fos expression in rostral ventromedial medulla. ULF-TENS may represent a novel and applicable therapeutic approach for improvement of orofacial pain induced by MMP.

show abstract

Ultra-low-frequency transcutaneous electric nerve stimulation (ULF-TENS) in subjects with craniofacial pain: A retrospective study

Cited by 27 publications

References 19 publications

A Device Improves Signs and Symptoms of TMD

A Device Improves Signs and Symptoms of TMD

Evaluation of Masticatory Muscle Function Using Digital versus Traditional Techniques for Mockup Fabrication: A Controlled Prospective Study

Ultra-Low Frequency Transcutaneous Electrical Nerve Stimulation on Pain Modulation in a Rat Model with Myogenous Temporomandibular Dysfunction

Contact Info

Product

Resources

About